AZITH

This brand name is authorized in Nigeria.

Active ingredients

The drug AZITH contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2236	Tablet	Azith-500 Tablets TAB 500 mg 1 x 3's (in Alu-Alu blister)	Film coated tablet A4-2236 Drugs Imported Product 13TABLETS 22-09-2024 HARVAD PHARMACEUTICALS COMPANY LIMITED, 20, JAYEOLA ABIDOYE STREET, THOMAS ESTATE, LEKKI, LAGOS STATE, NIGERIA. 12258876 amakego@yahoo.com Alpa Laboratories Limited ,, 33/2, A.B. Road Pigdamber - 453446, Indore (M.P.), India.	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2236